Top Suppliers:I want be here



235106-62-4

235106-62-4 structure
235106-62-4 structure
  • Name: VP 14637
  • Chemical Name: 2,2''-[(4-HYDROXYFENYL)METHYLEEN]BIS(4-{(E)-[(5-METHYL-1H-TETRAZOOL1-YL)IMINO]METHYL}FENOL)
  • CAS Number: 235106-62-4
  • Molecular Formula: C25H22N10O3
  • Molecular Weight: 510.51
  • Catalog: Signaling Pathways Anti-infection RSV
  • Create Date: 2018-06-02 09:24:58
  • Modify Date: 2024-08-27 11:18:34
  • MDT-637 (VP 14637) is a novel respiratory syncytial virus (RSV) fusion inhibitor with an IC50 of 1.42 ng/mL.

Name 2,2''-[(4-HYDROXYFENYL)METHYLEEN]BIS(4-{(E)-[(5-METHYL-1H-TETRAZOOL1-YL)IMINO]METHYL}FENOL)
Synonyms VP 14637
Description MDT-637 (VP 14637) is a novel respiratory syncytial virus (RSV) fusion inhibitor with an IC50 of 1.42 ng/mL.
Related Catalog
Target

IC50: 1.42 ng/mL (RSV)[1]

In Vitro MDT‐637 has broad in vitro antiviral activity on clinical strains of different RSV genotypes and clades. MDT-637 inhibits three laboratory strains (RSV-A Long, RSV-A2, and RSV-9320) and four clinical strains (RSV-Memphis-37, RSV-LAP0824, and RSV-HAN1135) with IC50s range from 0.36 to 3.4 ng/mL[1].
Cell Assay The laboratory and clinical isolates of RSV and various concentrations (ranging from 0.1 μM to 31.6 pM) of MDT‐637 (or ribavirin) are added to the HEp-2 cell monolayers at the same time. After 72 hours of incubation at 37°C, the cells and supernatants are harvested. An aliquot is immediately serially diluted and used for plaque assay[1].
References

[1]. Kim YI, et al. The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin. Influenza Other Respir Viruses. 2017 Nov;11(6):525-530.  

Molecular Formula C25H22N10O3
Molecular Weight 510.51
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.